Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Intangibles (2016 - 2025)

SRx Health Solutions' Intangibles history spans 8 years, with the latest figure at $1.1 million for Q2 2025.

  • For Q2 2025, Intangibles changed N/A year-over-year to $1.1 million; the TTM value through Jun 2025 reached $1.1 million, changed N/A, while the annual FY2023 figure was $14.7 million, 46.04% up from the prior year.
  • Intangibles reached $1.1 million in Q2 2025 per SRXH's latest filing, down from $7.0 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $14.7 million in Q3 2023 to a low of $1.1 million in Q2 2025.
  • Average Intangibles over 5 years is $10.5 million, with a median of $11.0 million recorded in 2022.
  • Peak YoY movement for Intangibles: surged 46.04% in 2023, then crashed 52.34% in 2024.
  • A 5-year view of Intangibles shows it stood at $11.6 million in 2021, then dropped by 13.18% to $10.1 million in 2022, then surged by 46.04% to $14.7 million in 2023, then plummeted by 52.34% to $7.0 million in 2024, then crashed by 83.95% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Intangibles are $1.1 million (Q2 2025), $7.0 million (Q3 2024), and $14.7 million (Q4 2023).